Joseph M. Manko, Jr., a Director and 10% Owner of KORU Medical Systems, Inc., filed a Form 4 on November 20, 2026, reporting a disposition of 43,208 shares of common stock at $0 per share through transaction code J, filed jointly with affiliated Horton Capital entities.

Key Highlights

  • Reporting persons: The filing was made jointly by Joseph M. Manko, Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, and Horton Capital Partners Fund, L.P., all located at 1717 Arch Street, 37th Floor, Philadelphia, Pennsylvania 19103.
  • Transaction: 43,208 shares of KORU Medical Systems common stock were disposed of (code J) on November 20, 2026, at a price of $0.
  • Post-transaction indirect ownership: Following the transaction, Horton Capital Partners Fund, LP holds 5,031,452 shares indirectly beneficially owned by Manko.
  • Direct ownership: Manko also reports 782,547 shares held directly following the reported transaction.
  • Roles reported: Manko is identified as both a Director and a 10% Owner; the Horton Capital entities are each identified as 10% Owners.
  • Exhibit referenced: The filing directs readers to Exhibit 99.1 for explanations of footnotes (1) and (2) relating to the transaction and indirect ownership.

Horton Capital Entities Report Joint Disposition of KORU Medical Common Stock

According to the filing, Joseph M. Manko, Jr. reported a single transaction in Table I involving common stock of KORU Medical Systems, Inc. (NASDAQ:KRMD). On November 20, 2026, 43,208 shares were disposed of under transaction code J at a price of $0. The filing does not define transaction code J beyond its reference to Exhibit 99.1, which the filing states contains the explanation for note (1) covering this transaction.

Following the reported transaction, the filing discloses that Manko indirectly beneficially owns 5,031,452 shares of common stock through Horton Capital Partners Fund, LP, and directly owns 782,547 shares. The form was filed jointly by four reporting persons: Manko individually, Horton Capital Management, LLC, Horton Capital Partners, LLC, and Horton Capital Partners Fund, L.P., all sharing the same Philadelphia address. Manko signed the form in his individual capacity and as Managing Member of each Horton entity, including as Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP.

The filing states that "the filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement." No derivative securities transactions were reported in Table II.

What Was Disclosed

A joint Form 4 filed November 20, 2026, by Joseph M. Manko, Jr. and three affiliated Horton Capital entities reported a disposition of 43,208 shares of KORU Medical Systems common stock at $0 via transaction code J, with post-transaction beneficial ownership of 5,031,452 shares indirectly and 782,547 shares directly.